Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Towards personalized allele-specific antisense oligonucleotide therapies for toxic gain-of-function neurodegenerative diseases
In alignment with Centers for Medicare & Medicaid Services (CMS) requirements, we recommend that the following information be included in the designated fields on drug-related medical claims: Applicable HCPCS or Current Procedural Terminology (CPT) codes Number of HCPCS or CPT code units 11-digit NDC, including the N4 qualifier Dosage unit of measurement (F2, GR, ML, or UN) Number of NDC units administered/dispensed (must be greater than 0) NDC coding applies to claims for outpatient services billed with: CMS-1500 for providers UB-04 for hospitals and facilities Electronic data interchange (EDI) 837 Note: This does not affect hospital or facility inpatient claims
Presented for research literature review only Tomonaga S et al
Debatri Datta March 11, 2024 Written By Dr
US$ 25.31
US$ 26.60
US$ 20.93
US$ 22.84
